These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30674089)

  • 1. Encapsulation of the Dinuclear Trithiolato-Bridged Arene Ruthenium Complex Diruthenium-1 in an Apoferritin Nanocage: Structure and Cytotoxicity.
    Petruk G; Monti DM; Ferraro G; Pica A; D'Elia L; Pane F; Amoresano A; Furrer J; Kowalski K; Merlino A
    ChemMedChem; 2019 Mar; 14(5):594-602. PubMed ID: 30674089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the in vitro Anticancer Effects of Diruthenium-1.
    Koceva-Chyła A; Matczak K; Hikisz MP; Durka MK; Kochel MK; Süss-Fink G; Furrer J; Kowalski K
    ChemMedChem; 2016 Oct; 11(19):2171-2187. PubMed ID: 27561129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quest of the best - A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties.
    Păunescu E; Boubaker G; Desiatkina O; Anghel N; Amdouni Y; Hemphill A; Furrer J
    Eur J Med Chem; 2021 Oct; 222():113610. PubMed ID: 34144354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.
    Stíbal D; Therrien B; Süss-Fink G; Nowak-Sliwinska P; Dyson PJ; Čermáková E; Řezáčová M; Tomšík P
    J Biol Inorg Chem; 2016 Jul; 21(4):443-52. PubMed ID: 27040952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro and in-vivo evaluation of the anticancer activity of diruthenium-2, a new trithiolato arene ruthenium complex [(η6-p-MeC6H4Pri)2Ru2(μ-S-p-C6H4OH)3]Cl.
    Muthná D; Tomšík P; Havelek R; Köhlerová R; Kasilingam V; Čermáková E; Stíbal D; Řezáčová M; Süss-Fink G
    Anticancer Drugs; 2016 Aug; 27(7):643-50. PubMed ID: 27187018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy-Dependent Apoptosis Induced by Apoferritin-Cu(II) Nanoparticles in Multidrug-Resistant Colon Cancer Cells.
    Xiong K; Zhou Y; Karges J; Du K; Shen J; Lin M; Wei F; Kou J; Chen Y; Ji L; Chao H
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):38959-38968. PubMed ID: 34379404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caged noble metals: Encapsulation of a cytotoxic platinum(II)-gold(I) compound within the ferritin nanocage.
    Ferraro G; Petruk G; Maiore L; Pane F; Amoresano A; Cinellu MA; Monti DM; Merlino A
    Int J Biol Macromol; 2018 Aug; 115():1116-1121. PubMed ID: 29709536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin-Tagged Dinuclear Trithiolato-Bridged Ruthenium(II)⋅Arene Complexes: Photophysical Properties and Antiparasitic Activity.
    Desiatkina O; Păunescu E; Mösching M; Anghel N; Boubaker G; Amdouni Y; Hemphill A; Furrer J
    Chembiochem; 2020 Oct; 21(19):2818-2835. PubMed ID: 32347622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.
    Brissos RF; Clavero P; Gallen A; Grabulosa A; Barrios LA; Caballero AB; Korrodi-Gregório L; Pérez-Tomás R; Muller G; Soto-Cerrato V; Gamez P
    Inorg Chem; 2018 Dec; 57(23):14786-14797. PubMed ID: 30444630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-soluble trithiolato-bridged dinuclear ruthenium(II) and osmium(II) arene complexes with bisphosphonate functionalized ligands as anticancer organometallics.
    Riedl CA; Rosner A; Harringer S; Salomon P; Hejl M; Jakupec MA; Kandioller W; Keppler BK
    J Inorg Biochem; 2021 Dec; 225():111618. PubMed ID: 34607124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
    Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
    Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.
    Dubarle-Offner J; Clavel CM; Gontard G; Dyson PJ; Amouri H
    Chemistry; 2014 May; 20(19):5795-801. PubMed ID: 24668791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carriers for metal complexes on tumour cells: the effect of cyclodextrins vs CNTs on the model guest phenanthroline-5,6-dione trithiacyclononane ruthenium(II) chloride.
    Braga SS; Marques J; Heister E; Diogo CV; Oliveira PJ; Paz FA; Santos TM; Marques MP
    Biometals; 2014 Jun; 27(3):507-25. PubMed ID: 24652595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin.
    Xing R; Wang X; Zhang C; Zhang Y; Wang Q; Yang Z; Guo Z
    J Inorg Biochem; 2009 Jul; 103(7):1039-44. PubMed ID: 19501911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: systematic solution studies.
    Nagy EM; Nardon C; Giovagnini L; Marchiò L; Trevisan A; Fregona D
    Dalton Trans; 2011 Nov; 40(44):11885-95. PubMed ID: 21971872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenoplatin-Ferritin Nanocage: Structure and Cytotoxicity.
    Ferraro G; Pratesi A; Cirri D; Imbimbo P; Maria Monti D; Messori L; Merlino A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel apoferritin formulations for antitumour benzothiazoles.
    Breen AF; Wells G; Turyanska L; Bradshaw TD
    Cancer Rep (Hoboken); 2019 Aug; 2(4):e1155. PubMed ID: 32721126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η
    Poljarević JM; Tamás Gál G; May NV; Spengler G; Dömötör O; Savić AR; Grgurić-Šipka S; Enyedy ÉA
    J Inorg Biochem; 2018 Apr; 181():74-85. PubMed ID: 29407910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.